{"id":22392,"date":"2022-01-17T13:49:49","date_gmt":"2022-01-17T13:49:49","guid":{"rendered":"https:\/\/www.theisn.org\/?page_id=22392"},"modified":"2026-09-30T20:35:35","modified_gmt":"2026-09-30T20:35:35","slug":"rare-kidney-diseases-toolkit","status":"publish","type":"page","link":"https:\/\/www.theisn.org\/initiatives\/rare-kidney-diseases-toolkit\/","title":{"rendered":"Rare Kidney Diseases Toolkit"},"content":{"rendered":"<p>[vc_row][vc_column]<div class=\"porto-sicon-box style_1 left-icon\"><div class=\"porto-sicon-body\"><div class=\"porto-sicon-description\" style=\"\">\n<h2>Rare Kidney DiseaseS Toolkit<\/h2>\n<p class=\"p1\">Serving as a curated resource, this toolkit aims to raise the profile of rare kidney diseases (RKDs), offer disease-specific tools, and understand and highlight the burden, gaps and unmet needs to fill.<\/p>\n<p class=\"p1\">Discover and access these tools<span class=\"apple-converted-space\">\u00a0<\/span>and resources<span class=\"apple-converted-space\">\u00a0<\/span>below.<\/p>\n<p><\/div> <!-- description --><\/div><\/div><!-- porto-sicon-box -->[\/vc_column][\/vc_row][vc_row equal_height=&#8221;yes&#8221; content_placement=&#8221;bottom&#8221;][vc_column][vc_tta_accordion spacing=&#8221;5&#8243; gap=&#8221;5&#8243; c_position=&#8221;right&#8221; active_section=&#8221;&#8221; collapsible_all=&#8221;true&#8221; el_class=&#8221;accordion-isn&#8221;][vc_tta_section title=&#8221;New! Rare Kidney Disease Directory&#8221; tab_id=&#8221;Directory&#8221;][vc_column_text]This resource provides a list of rare kidney diseases, categorized and linked to their corresponding Orphanet codes (where possible). Access the directory <a href=\"https:\/\/www.theisn.org\/rkd_directory\/\">here<\/a>.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Disease Specific Resources&#8221; tab_id=&#8221;Disease-Specific&#8221;][vc_empty_space height=&#8221;15px&#8221;][vc_toggle title=&#8221;aHUS&#8221;]<\/p>\n<ul>\n<li><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00705-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum<\/a><\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;ADPKD&#8221;]<\/p>\n<div>\n<div class=\"float-left\"><a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/07\/ADPKD-Infographic.pdf\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-48422 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/07\/ADPKD-Infographic-Image-213x300.png\" alt=\"\" width=\"106\" height=\"149\" \/> <\/a>This infographic provides an overview of ADPKD, including information on diagnosis, delaying kidney disease progression, complications, and additional considerations<\/div>\n<div class=\"float-left\"><a href=\"https:\/\/x.com\/ISNkidneycare\/status\/1895460390718624169\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-49674 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/10\/PKD-Quiz-scaled.jpg\" alt=\"\" width=\"191\" height=\"191\" \/><\/a> Test your knowledge on Polycystic Kidney Disease by taking this quiz<\/div>\n<div class=\"float-left\"><a href=\"https:\/\/x.com\/i\/spaces\/1lDxLBvemrwGm\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-49673 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/10\/Space-PKD-Day-scaled.jpg\" alt=\"\" width=\"189\" height=\"138\" \/><\/a> Twitter Space in recognition of World PKD Day.<\/div>\n<div class=\"float-left\"><a href=\"https:\/\/x.com\/ISNkidneycare\/status\/1963255568233009505\"><strong>Tweetorial on PKD can be found here.\u00a0<\/strong><\/a><\/div>\n<\/div>\n<p>[\/vc_toggle][vc_toggle title=&#8221;C3G&#8221;]<\/p>\n<div class=\"faq-grid\">\n<div>\n<div class=\"float-left\" style=\"text-align: center\">\n<p id=\"product-title\" class=\"product-favorites\" data-id=\"195325\"><a href=\"https:\/\/academy.theisn.org\/products\/isn-webinar-advancements-in-c3-glomerulopathy#tab-product_tab_overview\" target=\"_blank\" rel=\"noopener\">ISN Webinar: Advancements in C3 Glomerulopathy<img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-42773 size-medium\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/10\/C3G-1-300x211.jpeg\" alt=\"\" width=\"300\" height=\"211\" \/><\/a><\/p>\n<\/div>\n<div class=\"float-left\" style=\"text-align: center\">Overview C3G Infographic<br \/>\n<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/09\/C3G_Overview-Infographic.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-35951 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/11\/C3G_Overview-Infographic-e1695319862617-233x300-1.png\" alt=\"\" width=\"109\" height=\"140\" \/><\/a><\/div>\n<div class=\"float-left\" style=\"text-align: center\">In-Depth C3G Infographic<br \/>\n<a style=\"text-align: center\" href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/09\/C3G.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-33575 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/09\/C3G-In-Depth-Infographic-300x169.png\" alt=\"\" width=\"211\" height=\"119\" \/><br \/>\n<\/a><\/div>\n<\/div>\n<div>\n<div class=\"float-left\">\n<p style=\"text-align: center\">\u00a0C3G Basic Primer<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-39200 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/05\/RKD-Toolkit_C3G-Primer-233x300.png\" alt=\"\" width=\"115\" height=\"148\" \/><br \/>\n<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/05\/C3G_-Primer_English.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a> \u00a0|<br \/>\n<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/06\/C3G-Primer_Japanese.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Japanese<\/a> \u00a0|<br \/>\n<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/06\/C3G-Primer_Chinese.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Chinese<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>*Please note the C3G resources will be updated after April 2026.[\/vc_toggle][vc_toggle title=&#8221;Fibromuscular Dysplasia&#8221;]<a href=\"https:\/\/academy.theisn.org\/products\/rare-diseases-fibromuscular-dysplasia\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-45869 alignleft\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/02\/2024-01-Rare-Disease-Fibromuscular-dysplasia-curriculum-CME-300x250-banner-for-KI.jpg\" alt=\"\" width=\"195\" height=\"160\" \/><\/a><\/p>\n<p>This curriculum will provide an up-to-date review on the pathophysiology, diagnosis and management of FMD.[\/vc_toggle][vc_toggle title=&#8221;IgA Nephropathy&#8221;]<\/p>\n<div class=\"faq-grid\">\n<div>\n<div class=\"float-left\" style=\"text-align: center\">\n<p id=\"product-title\" class=\"product-favorites\" data-id=\"194630\"><a href=\"https:\/\/academy.theisn.org\/products\/isneducation-nuances-in-nephrology-webinar-advancements-and-innovations-in-iga-nephropathy-diagnosis-treatment-and-management#tab-product_tab_overview\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-42761\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/10\/IgAN-300x205.jpeg\" alt=\"\" width=\"227\" height=\"155\" \/><\/a><br \/>\n<a href=\"https:\/\/academy.theisn.org\/products\/isneducation-nuances-in-nephrology-webinar-advancements-and-innovations-in-iga-nephropathy-diagnosis-treatment-and-management#tab-product_tab_overview\" target=\"_blank\" rel=\"noopener\">ISNeducation Nuances in Nephrology Webinar: Advancements and<br \/>\nInnovations in IgA Nephropathy: Diagnosis, Treatment, and<br \/>\nManagement<\/a><\/p>\n<\/div>\n<div class=\"float-left\" style=\"text-align: center\"><a href=\"https:\/\/globalkidneycarepodcast.transistor.fm\/episodes\/season-4-episode-7-changing-treatment-landscape-in-igan-and-disease-modification-approaches\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-42760\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/10\/isn-gkc-podcast-300x300.jpg\" alt=\"\" width=\"176\" height=\"176\" \/><\/a><br \/>\n<a href=\"https:\/\/globalkidneycarepodcast.transistor.fm\/episodes\/season-4-episode-7-changing-treatment-landscape-in-igan-and-disease-modification-approaches\" target=\"_blank\" rel=\"noopener noreferrer\">ISN Global Kidney Care Podcast: Changing Treatment Landscape in IgAN<br \/>\nand Disease Modification Approaches<\/a><\/div>\n<div class=\"float-left\" style=\"text-align: center\"><a href=\"https:\/\/share.transistor.fm\/s\/e162fea7\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-42760\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/10\/isn-gkc-podcast-300x300.jpg\" alt=\"\" width=\"176\" height=\"176\" \/><\/a><br \/>\n<a href=\"https:\/\/share.transistor.fm\/s\/e162fea7\" target=\"_blank\" rel=\"noopener noreferrer\">ISN Global Kidney Care Podcast: Discussion on IgA Nephropathy: as part<br \/>\nof the NephMadness PodCrawl<\/a><\/div>\n<\/div>\n<div>\n<div class=\"float-left\" style=\"text-align: center\">\n<p><a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/IgAN-Visual-Abstract.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-33028 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/IgAN-Visual-Abstract-300x169.jpg\" alt=\"\" width=\"263\" height=\"148\" \/><\/a><br \/>\nVisual Abstract on the Diagnosis, Management and Treatment of IgA<br \/>\nNephropathy in 2023 and Beyond. View the abstract<br \/>\n<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/IgAN-Visual-Abstract.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/p>\n<\/div>\n<div class=\"float-left\" style=\"text-align: center\"><a href=\"https:\/\/academy.theisn.org\/products\/iga-nephropathy-curriculum\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-49632 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/10\/Academy.jpg\" alt=\"\" width=\"229\" height=\"129\" \/>IgA Nephropathy Curriculum<\/a><\/div>\n<\/div>\n<\/div>\n<p>[\/vc_toggle][vc_toggle title=&#8221;Monoclonal Gammopathy of Renal Significance (MGRS) and Amyloidosis&#8221;]<strong><a href=\"https:\/\/academy.theisn.org\/products\/rare-diseases-mgrs-and-amyloidosis-course\" target=\"_blank\" rel=\"noopener noreferrer\">NEW! ISN Academy: MGRS and Amyloidosis Course<\/a><\/strong><br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\" wp-image-46405 alignleft\" style=\"margin-right: 35px\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/03\/2025-03-Rare-Disease-MGRS-and-Amyloidosis-curriculum-visual-300x238.png\" alt=\"\" width=\"195\" height=\"151\" \/><br \/>\nCourse participants will learn how to:<\/p>\n<ul style=\"margin-left: 30px\">\n<li>Define the different types of MGRS and of amyloidosis affecting the kidney and estimate their prevalence<\/li>\n<li>Describe the pathogenesis of MGRS and of amyloidosis-related kidney disease<\/li>\n<li>Discuss the diagnostic evaluation of patients with MGRS and patients with different types of amyloidosis<\/li>\n<li>Illustrate the current principles of management of MGRS and the different types of amyloidosis affecting the kidney and the role of kidney transplantation<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;Lupus Nephritis&#8221;]<\/p>\n<ul>\n<li>How well do you understand Lupus Nephritis? Take the ISN quiz <a href=\"https:\/\/theisn.outgrow.us\/lupus-nephritis\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/li>\n<li><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00627-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5b08e1234f-ISN-Trending+Topics&amp;utm_medium=email&amp;utm_term=0_-5b08e1234f-%5BLIST_EMAIL_ID%5D\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS<\/a><\/li>\n<\/ul>\n<p>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=&#8221;Resources on the Complement System&#8221; tab_id=&#8221;Complement-System&#8221;][vc_empty_space height=&#8221;20px&#8221;][vc_row_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\">Animation on the Complement System and Related Kidney Diseases, with narration<\/h4>\n<p>[\/vc_column_text][vc_video link=&#8221;https:\/\/www.youtube.com\/watch?v=4789DQohXbU&#8221; el_width=&#8221;80&#8243; align=&#8221;center&#8221;][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\">Infographic on the Complement System and Related Kidney Diseases, with narration<\/h4>\n<p>[\/vc_column_text][vc_column_text]<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/media\/Complement-pathway-commentary\/#page=1\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-25744 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2022\/07\/Intro-to-Complement-System-Infographic-300x168.png\" alt=\"\" width=\"317\" height=\"177\" \/><\/a><\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/09\/Complement-pathway-commentary_Final_Updated.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Download the infographic.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space][vc_text_separator title=&#8221;Additional Resources on the Complement System&#8221;][vc_empty_space height=&#8221;20px&#8221;][vc_toggle title=&#8221;ISN Complement Pathway Disease Curriculum&#8221;]<a href=\"https:\/\/academy.theisn.org\/products\/rare-diseases-complement-pathway-disease-curriculum#tab-product_tab_overview\" target=\"_blank\" rel=\"noopener noreferrer\">ISN Complement Pathway Disease Curriculum<\/a><br \/>\nThis curriculum will provide a comprehensive review of the pathophysiology, diagnosis and management of various complement-mediated kidney diseases. The seven modules are:<\/p>\n<ul>\n<li>Module 1: Basics of the Complement System<\/li>\n<li>Module 2: Thrombotic Microangiopathies (TMA\/aHUS)<\/li>\n<li>Module 3: C3G<\/li>\n<li>Module 4: Lupus<\/li>\n<li>Module 5: ANCA Vasculitis<\/li>\n<li>Module 6: Emerging Role and Understanding of Complement in IgAN: Potential for Therapeutics<\/li>\n<li>Module 7: The Multifaceted Role of Complement in Kidney Transplant and Rejection: Lessons Learned and Future Direction<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;ISN Quiz on Complement mediated Glomerulopathies&#8221;]<\/p>\n<p style=\"text-align: center\">What do you know about Complement mediated Glomerulopathies? Take the quiz <a href=\"https:\/\/theisn.outgrow.us\/c3GN\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/p>\n<p><a href=\"https:\/\/theisn.outgrow.us\/c3GN\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-27339 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2022\/11\/September-300x187.jpg\" alt=\"\" width=\"245\" height=\"153\" \/><\/a>[\/vc_toggle][vc_toggle title=&#8221;ISN-KDIGO Webinar Series on Complement in CKD&#8221;]All of the recorded versions of the pre-webinar series leading up to KDIGO\u2019s Controversies Conference on the Role of Complement in Kidney Disease can be found below.<\/p>\n<ul>\n<li><a href=\"https:\/\/academy.theisn.org\/products\/whats-new-in-the-management-and-treatment-of-glomerulonephritis-dissecting-the-role-of-complement-in-glomerulonephritis-with-a-focus-on-c3g#tab-product_tab_overview\" target=\"_blank\" rel=\"noopener noreferrer\">Webinar 1: Dissecting the Role of Complement in Glomerulonephritis with a Focus on C3G<\/a><\/li>\n<li><a href=\"https:\/\/academy.theisn.org\/products\/whats-new-in-the-management-and-treatment-of-gn-a-look-at-anca-and-ln?packages%5B%5D=119095&amp;in_package=119095&amp;sort_by=package_order&amp;ref=package&amp;ref_id=119095\" target=\"_blank\" rel=\"noopener noreferrer\">Webinar 2: What\u2019s New in the Management and Treatment of GN: A look at ANCA and LN<\/a><\/li>\n<li><a href=\"https:\/\/academy.theisn.org\/products\/whats-new-in-the-management-and-treatment-of-glomerulonephritis-a-look-at-igan-and-mn?packages%5B%5D=119095&amp;in_package=119095&amp;sort_by=package_order&amp;ref=package&amp;ref_id=119095\" target=\"_blank\" rel=\"noopener noreferrer\">Webinar 3: What&#8217;s New in the Management and Treatment of Glomerulonephritis: A look at IgAN and MN<\/a><\/li>\n<li><a href=\"https:\/\/academy.theisn.org\/products\/whats-new-in-the-management-and-treatment-of-glomerulonephritis-role-of-complement-beyond-glomerulonephritis-transplantation-dkd?packages%5B%5D=119095&amp;in_package=119095&amp;sort_by=package_order&amp;ref=package&amp;ref_id=119095\" target=\"_blank\" rel=\"noopener noreferrer\">Webinar 4:\u00a0Role of Complement Beyond Glomerulonephritis (transplantation, DKD)<\/a><\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;ISN Global Kidney Care Podcast on CMKDs&#8221;]<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-38802 alignleft\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/05\/img-podcast-300x202.jpg\" alt=\"\" width=\"116\" height=\"78\" \/>In <strong><a href=\"https:\/\/share.transistor.fm\/s\/ca9d6c10\" target=\"_blank\" rel=\"noopener noreferrer\">this podcast<\/a><\/strong>, Drs Namrata Parikh, Gary Chan and Nick Medjeral-Thomas discuss key clinical and pathology features of inappropriate, pathogenic complement activity that guide physicians to a diagnosis of C3 glomerulopathy. They discuss differences in investigation and management strategies between their respective clinical centers in Ottawa, Hong Kong and London, including access to clinical trials of therapeutic complement inhibitors. To finish, they speculated on the future impact on clinical nephrology of complement pathway analysis and inhibition.[\/vc_toggle][vc_toggle title=&#8221;ISN October 2022 eDigest on CMKDs&#8221;]ISN\u2019s October \u201922 eDigest\u00a0presents recent publications in Kidney International Reports\u00a0on the pathophysiology, progression, treatment, and validation of complement-mediated kidney diseases. It also\u00a0highlights four original papers, in the field of complement-mediated kidney diseases, that have been published in Kidney International within the past few months. <strong><a href=\"https:\/\/www.theisn.org\/edigest-sept-2022\/\" target=\"_blank\" rel=\"noopener noreferrer\">Explore the eDigest here.<\/a><\/strong>[\/vc_toggle][vc_toggle title=&#8221;ISN Frontiers Webinars&#8221;]<a href=\"https:\/\/academy.theisn.org\/products\/isn-frontiers-webinar-new-insights-into-clinical-management-of-complement-mediated-thrombotic-microangiopathies#tab-product_tab_contents__1\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-23588\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2022\/03\/CMKD-Toolkit_ISN-Frontiers-1-300x169.png\" alt=\"\" width=\"331\" height=\"186\" \/> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/a><a href=\"https:\/\/academy.theisn.org\/products\/isn-frontiers-webinar-new-insights-into-clinical-management-of-c3g#tab-product_tab_contents__1\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-23939\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2022\/03\/Frontiers-Webinar-2-300x168.png\" alt=\"\" width=\"331\" height=\"186\" \/><\/a>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=&#8221;general resources&#8221; tab_id=&#8221;Articles&#8221;]<div class=\"porto-sicon-box style_1 default-icon\"><div class=\"porto-sicon-default\"><div id=\"porto-icon-8407369746ae83123740a4\" class=\"porto-just-icon-wrapper\" style=\"text-align:center;\"><div class=\"porto-icon none\" style=\"color:#66cccc;font-size:36px;display:inline-block;\"><i class=\"fab fa-twitter\"><\/i><\/div><\/div><\/div><div class=\"porto-sicon-header\" ><a class=\"porto-sicon-box-link\" href=\"https:\/\/x.com\/ISNkidneycare\/status\/1895460390718624169\" target='_blank'><h4 class=\"porto-sicon-title\" style=\"\">Rare Kidney Diseases: Unmasking the Zebras in Nephrology!<\/h4><\/a><p style=\"font-weight:H6;font-size:H6;\">Tweetorial<\/p><\/div> <!-- header --><\/div><!-- porto-sicon-box -->[\/vc_tta_section][vc_tta_section title=&#8221;Advocacy for Rare Kidney Diseases&#8221; tab_id=&#8221;Advocacy&#8221;][vc_row_inner][vc_column_inner width=&#8221;1\/3&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\">Rare Kidney Disease Fact Sheet<\/h4>\n<p>[\/vc_column_text][vc_single_image image=&#8221;47699&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; onclick=&#8221;custom_link&#8221; img_link_target=&#8221;_blank&#8221; link=&#8221;https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/05\/RKD-Fact-Sheet_English-1.pdf&#8221;][vc_column_text]<\/p>\n<h5 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/05\/RKD-Fact-Sheet_English-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">English<\/a>\u00a0|\u00a0 <a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/08\/RKD-Fact-Sheet_Arabic.pdf\" target=\"_blank\" rel=\"noopener\">Arabic<\/a>\u00a0|\u00a0 <a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/06\/RKD-Fact-Sheet_Chinese.pdf\" target=\"_blank\" rel=\"noopener\">Chinese<\/a> |\u00a0 <a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/06\/RKD-Fact-Sheet_French.pdf\" target=\"_blank\" rel=\"noopener\">French<\/a> |\u00a0 <a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/06\/RKD-Fact-Sheet_Japanese.pdf\" target=\"_blank\" rel=\"noopener\">Japanese<\/a>\u00a0| \u00a0<a href=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/05\/RKD-Fact-Sheet_Spanish.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Spanish<\/a><\/h5>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/3&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner]<div class=\"porto-sicon-box style_1 default-icon\"><div class=\"porto-sicon-default\"><div id=\"porto-icon-15919076096ae831237416e\" class=\"porto-just-icon-wrapper\" style=\"text-align:center;\"><div class=\"porto-icon none\" style=\"color:#6fc8bb;font-size:36px;display:inline-block;\"><i class=\"fas fa-file-alt\"><\/i><\/div><\/div><\/div><div class=\"porto-sicon-header\" ><a class=\"porto-sicon-box-link\" href=\"https:\/\/www.asn-online.org\/education\/kidneyweek\/2022\/program-abstract.aspx?controlId=3768337\" target='_blank'><h4 class=\"porto-sicon-title\" style=\"\">Identification of Neglected Kidney Diseases: Results From an International Survey<\/h4><\/a><p style=\"font-weight:H6;font-size:H6;\">ASN Kidney Week 2022 Abstract<\/p><\/div> <!-- header --><\/div><!-- porto-sicon-box --><div class=\"porto-sicon-box style_1 default-icon\"><div class=\"porto-sicon-default\"><div id=\"porto-icon-911916566ae8312374212\" class=\"porto-just-icon-wrapper\" style=\"text-align:center;\"><div class=\"porto-icon none\" style=\"color:#6fc8bb;font-size:36px;display:inline-block;\"><i class=\"fas fa-file-alt\"><\/i><\/div><\/div><\/div><div class=\"porto-sicon-header\" ><a class=\"porto-sicon-box-link\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01922-3\/fulltext\" target='_blank'><h4 class=\"porto-sicon-title\" style=\"\">Scoping Review of Economic Analyses of Rare Kidney Diseases<\/h4><\/a><p style=\"font-weight:H6;font-size:H6;\">Kidney International Reports, September 2024<\/p><\/div> <!-- header --><\/div><!-- porto-sicon-box --><div class=\"porto-sicon-box style_1 default-icon\"><div class=\"porto-sicon-default\"><div id=\"porto-icon-13633745996ae83123742d2\" class=\"porto-just-icon-wrapper\" style=\"text-align:center;\"><div class=\"porto-icon none\" style=\"color:#6fc8bb;font-size:36px;display:inline-block;\"><i class=\"fas fa-file-alt\"><\/i><\/div><\/div><\/div><div class=\"porto-sicon-header\" ><a class=\"porto-sicon-box-link\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03404-1\/fulltext\" target='_blank'><h4 class=\"porto-sicon-title\" style=\"\">Systematic Scoping Review of Socioeconomic Burden and Associated Psychosocial Impact in Patients With Rare Kidney Diseases and Their Caregivers<\/h4><\/a><p style=\"font-weight:H6;font-size:H6;\">Kidney International Reports, December 2024<\/p><\/div> <!-- header --><\/div><!-- porto-sicon-box -->[\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=&#8221;In-Person Events&#8221; tab_id=&#8221;Events&#8221;][vc_row_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1715778170845{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/gn-course\/\" target=\"_blank\" rel=\"noopener noreferrer\">GN Primer Course &#8211; Tokyo 2023<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1715778290384{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/ahus-international-forum\/\" target=\"_blank\" rel=\"noopener noreferrer\">Expert Forum on aHUS &#8211; 2023<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1715778333278{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/primer-course-in-glomerular-diseases-la-2024\" target=\"_blank\" rel=\"noopener noreferrer\">GN Pre-Congress Course &#8211; WCN &#8217;24<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1721136642230{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/gn-course-china\/\" target=\"_blank\" rel=\"noopener noreferrer\">GN Primer Course &#8211; China 2024<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1747998082325{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/c3g-igan-budapest-hungary\/\" target=\"_blank\" rel=\"noopener\">Expert Forum on Complement Therapeutics in C3G &amp; IgAN &#8211; 2025<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1715778170845{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/gn-course-nairobi\/\" target=\"_blank\" rel=\"noopener noreferrer\">GN Primer Course &#8211; Kenya 2025<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1747998471107{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/gn_prague\/\" target=\"_blank\" rel=\"noopener noreferrer\">GN Primer Course &#8211; Prague 2025<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=&#8221;box-blue-isn&#8221; width=&#8221;1\/5&#8243; css=&#8221;.vc_custom_1747998541419{background-image: url(https:\/\/www.theisn.org\/wp-content\/uploads\/2021\/02\/educational-program.jpg?id=13323) !important;}&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\"><a href=\"https:\/\/www.theisn.org\/in-action\/education\/in-person-courses\/primer-course-in-glomerular-diseases-apcn2025\/\" target=\"_blank\" rel=\"noopener\">GN Primer Course &#8211; Taipei 2025<\/a><\/h4>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/5&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/5&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section title=&#8221;ISN Fellowship Opportunity in Glomerular Diseases&#8221; tab_id=&#8221;Fellowship&#8221;][vc_column_text]<strong>New Specialized ISN Fellowship Opportunity in Glomerular Disease Training<\/strong><\/p>\n<div><\/div>\n<p>The ISN has joined forces with Otsuka Pharmaceutical to support specialized nephrology training in glomerular diseases. This partnership will provide aspiring kidney care professionals with hands-on experience and mentorship in this essential area of nephrology expertise.<\/p>\n<div><\/div>\n<p>If you\u2019re looking to advance your expertise in glomerular diseases, <span lang=\"EN-US\">the <\/span>next ISN Fellowship application deadline is <strong><span lang=\"EN-US\">October<\/span><\/strong><strong> 1<\/strong>.\u00a0<span lang=\"EN-US\">Applications will open on July 1.<\/span><\/p>\n<div><\/div>\n<p><a title=\"https:\/\/www.theisn.org\/in-action\/grants\/fellowship\/#special-fellow\" href=\"https:\/\/www.theisn.org\/in-action\/grants\/fellowship\/#special-fellow\" target=\"_blank\" rel=\"noopener\"><strong>Find out more and apply here<\/strong><\/a><span lang=\"EN-US\">.<\/span>[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;WCN resources on RKDs&#8221; tab_id=&#8221;Additional-Resources&#8221;][vc_column_text]<\/p>\n<h4><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-37281\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/01\/WCN25-logo-300x120.png\" alt=\"\" width=\"110\" height=\"42\" \/>\u00a0 \u00a0 \u00a0 \u00a0Access WCN &#8217;25 sessions on rare kidney diseases <a href=\"https:\/\/academy.theisn.org\/products\/wcn25-the-smart-kidney#tab-product_tab_content\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/h4>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<h4><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-37281\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/01\/2024-01-WCN24-regular-fee-website-homepage-banner-WCN-logo-300x103.png\" alt=\"\" width=\"110\" height=\"42\" \/>\u00a0 \u00a0 \u00a0 \u00a0Access WCN &#8217;24 sessions on rare kidney diseases <a href=\"https:\/\/academy.theisn.org\/products\/wcn24-the-smart-kidney#tab-product_tab_content\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/h4>\n<p>[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Acknowledgments&#8221; tab_id=&#8221;1647508653447-964b9d3c-1b2f&#8221;][vc_toggle title=&#8221;Steering Committee Members&#8221;]<\/p>\n<ul>\n<li>Vladim\u00edr Tesa\u0159 |\u00a0Czech Republic<\/li>\n<li>Sydney Tang | Hong Kong<\/li>\n<li>Liz Lightstone | UK<\/li>\n<li>Vivekanand Jha | India<\/li>\n<li>Jonathan Barratt | UK<\/li>\n<li>Ifeoma Ulasi | Nigeria<\/li>\n<li>David Kavanagh | UK<\/li>\n<li>Olivier Devuyst |\u00a0Switzerland \/ Belgium<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;Tool Developers&#8221;]<\/p>\n<ul>\n<li>Namrata Parikh | USA<\/li>\n<li>Becky Mingyao Ma | Hong Kong<\/li>\n<li>Gary Chan | Hong Kong<\/li>\n<li>Nicholas Medjeral-Thomas | UK<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_empty_space height=&#8221;16px&#8221;][vc_column_text]<\/p>\n<h5>Thank you to our reviewers and translators: Dina Abdellatif, Fernanda Arce, Henry Wu, Lili Zhou, Sonia Guillouet,\u00a0 Yoichiro Ikeda and the Scientific Committee of the Japanese Society of Nephrology.<\/h5>\n<p>[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Copyright and Permissions&#8221; tab_id=&#8221;1695203400468-4ba31337-3b42&#8243;][vc_column_text]This toolkit material is freely available for download by healthcare professionals and individual usage. For-profit organizations may link to toolkit materials with appropriate referencing but are not allowed to use the materials directly (including screenshots) in their own activities; and, where the toolkit materials are referenced with a link, society logos may not be used or displayed with the link. Non-profit organizations may link to the toolkit materials with appropriate referencing, and may promote the materials directly, but must seek permission for this first. If you have any questions concerning the rights to use these materials, please contact <a title=\"mailto:mmoorthy@theisn.org\" href=\"mailto:mmoorthy@theisn.org\">mmoorthy@theisn.org<\/a>.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Support&#8221; tab_id=&#8221;Support&#8221;][vc_column_text]<\/p>\n<h4 style=\"text-align: center\">The Rare Kidney Diseases Toolkit is supported by<\/h4>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_column_text]<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-43546 aligncenter\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2024\/12\/Roche_Logo.svg-300x163.png\" alt=\"\" width=\"164\" height=\"89\" \/>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][vc_empty_space height=&#8221;8px&#8221;][vc_column_text]<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-44332 aligncenter sobi\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2025\/01\/Sobi-300x113.png\" alt=\"\" width=\"196\" height=\"74\" \/>[\/vc_column_text]<script>\n\t\t(function($){\n\t\t\t$(\"head\").append(\"<style>.mfp-bg.mfp-fade { background-color:rgba(76,76,76,0.8); }<\/style>\");\n\t\t})(jQuery);\n\t\t<\/script><div class=\"porto-modal-input-wrapper \"><script>\n\t(function($){\n\t\t$(document).ready(function(){\n\t\t\tvar selector = \".sobi\";\n\t\t\t$(selector).addClass(\"porto-modal-trigger\");\n\t\t\t$(selector).attr(\"data-trigger-id\", \"porto-modal-6ae831237436e2-98911494\");\n\t\t\t$(selector).attr(\"data-type\", \"inline\");\n\t\t\t$(selector).attr(\"data-overlay-class\", \"mfp-fade\");\n\t\t});\n\t})(jQuery);\n\t<\/script><\/div><div id=\"porto-modal-6ae831237436e2-98911494\" class=\"mfp-hide \"><div class=\"porto-modal-content\">Within the therapeutic area of Immunology, <a href=\"https:\/\/www.sobi.com\/en\" target=\"_blank\" rel=\"noopener\">Sobi<\/a> is dedicated to the treatment of rare, ultra-rare and severe diseases. This dedication combined with a rare expertise has resulted in a long history of developing transformative treatments for patients with high unmet medical needs.<\/p>\n<p>Our ability to identify unmet medical needs, develop treatments and secure evidence has been instrumental in the success of our current therapies. Our track record in getting innovative treatments to the people who need them positions us well to take a leading role in Immunology.<\/p>\n<p>We keep challenging the status quo and are dedicated to the continuous discovery of high-potential therapies that we can develop to make a lasting impact and create sustainable value, sooner rather than later. Through close collaboration with rare disease communities, we continue to improve access to care for those otherwise overlooked.<\/div><\/div>[\/vc_column_inner][vc_column_inner width=&#8221;1\/4&#8243;][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n<h6 style=\"text-align: center\">The Rare Kidney Diseases Toolkit has been developed with support from unrestricted educational grants from Alexion, AstraZeneca Rare Disease, OtsukaNovartis and Roche.<\/h6>\n<p>[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;50px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][vc_message message_box_color=&#8221;grey&#8221; icon_fontawesome=&#8221;fas fa-exclamation-triangle&#8221; el_class=&#8221;ref&#8221;]<em><strong>Disclaimer text:<\/strong> This toolkit is intended to facilitate decision making of health professionals in their daily practice. However, final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. The ISN declines any responsibilities for any damage caused by the use that may be made of the information provided in this toolkit.<\/em>[\/vc_message][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][\/vc_column][\/vc_row][vc_row equal_height=&#8221;yes&#8221; content_placement=&#8221;bottom&#8221;][vc_column][vc_tta_accordion spacing=&#8221;5&#8243; gap=&#8221;5&#8243; c_position=&#8221;right&#8221; active_section=&#8221;&#8221; collapsible_all=&#8221;true&#8221; el_class=&#8221;accordion-isn&#8221;][vc_tta_section title=&#8221;New! Rare Kidney Disease Directory&#8221; tab_id=&#8221;Directory&#8221;][vc_column_text]This resource provides a list of rare kidney diseases, categorized and linked to their corresponding Orphanet codes (where possible). Access the directory here.[\/vc_column_text][\/vc_tta_section][vc_tta_section title=&#8221;Disease Specific Resources&#8221; tab_id=&#8221;Disease-Specific&#8221;][vc_empty_space height=&#8221;15px&#8221;][vc_toggle title=&#8221;aHUS&#8221;] Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":0,"parent":3569,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-22392","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/22392"}],"collection":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/comments?post=22392"}],"version-history":[{"count":11,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/22392\/revisions"}],"predecessor-version":[{"id":55686,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/22392\/revisions\/55686"}],"up":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/3569"}],"wp:attachment":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/media?parent=22392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}